Clinical Trial Update: Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating standard chemotherapy plus moxifloxacin as first-line treatment for metastatic triple-negative breast cancer and is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Moxifloxacin (moxifloxacin)

Snippet

Sponsor: Sun Yat-Sen University Cancer Center | Conditions: Triple Negative Breast Cancer | Phase 3 | Status: RECRUITING